Gene One Life Science unit VGXI extends buyback option on Conroe plant to Dec. 15 for USD 39.9 million

Bitget2026/09/23 05:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gene One Life Science’s unit VGXI extended the buyback-option window tied to its Conroe Plant 2 deed-in-lieu financing.
New option maturity set for Dec. 15, 2026, from Sept. 1, 2026, extending the deadline by about 3.5 months.
Total buyback price set at USD 39.9 million, including amounts for accrued interest, fees, lease costs, holding costs, premium.
Payment schedule calls for USD 2 million on Oct. 7, USD 2 million on Oct. 30, balance USD 35.9 million on Dec. 15.
Board decision date for the extension agreement: Sept. 23, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923800336), on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gene One Life Science unit VGXI extends buyback option on Conroe plant to Dec. 15 for USD 39.9 million

You may also like

Crypto prices